The Bill Silverman Prize is offered annually and explicitly acknowledges Cochrane's value of criticism, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions. The Cochrane Steering Group approved the establishment of the Prize in 2007, and it was awarded for the first time in 2008.
Please note that this Prize is not for the preparation of a Cochrane Review; rather, it is for a published paper which demonstrates originality and critical thinking, either in evaluating any aspect of the preparation, maintenance or dissemination of Cochrane Reviews or about the work of Cochrane more generally. It should be of high quality, have been accompanied by constructive suggestions on how the relevant aspects of Cochrane’s work could be improved; and have had, or is likely to have, a positive impact on the scientific quality, relevance and use of Cochrane Reviews.
Peer-reviewed papers that fulfil the criteria described above under ‘Purpose’, and were published in the twelve-month period 1 April 2020 to 31 March 2021 are eligible for nomination in 2021. Papers of critique of a single Cochrane review are not considered for the prize.
Nominations can be made by anyone, including the authors of the publication being nominated. Nominations should be submitted via this online form. The deadline for receipt of nominations is 31 October 2021.The winners of the 2021 prize will be announced in a virtual ceremony later in the year.
Everyone in the Cochrane Community is welcome to submit nominations. You may nominate multiple people but each nomination must be submitted through a separate form. You have until the 31 October 2021 to make your nominations.